Skip to main content
Dana Matthews, MD, Pediatric Hematology & Oncology, Seattle, WA, Seattle Children's Hospital

DanaCMatthewsMD

Pediatric Hematology & Oncology Seattle, WA

Associate Professor of Pediatrics, University Wash

Dr. Matthews is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Matthews' full profile

Already have an account?

Education & Training

  • Duke University Hospital
    Duke University HospitalResidency, Pediatrics, 1981 - 1984
  • University of Washington School of Medicine
    University of Washington School of MedicineClass of 1981
  • University of Washington
    University of WashingtonB.S., Psychology, 1975 - 1977
  • Whitman College
    Whitman CollegeNo Degree, 1973 - 1975

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 1984 - 2023
  • American Board of Pediatrics Pediatrics

Awards, Honors, & Recognition

  • Scholar in Clinical Research Leukemia and Lymphoma Society, 1999
  • Alpha Omega Alpha University of Washington, 1981
  • Phi Beta Kappa University of Washington, 1977
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • T cells from three hemophilia A subjects recognized the same HLA-restricted FVIII epitope with a narrow TCR repertoire  
    Ettinger, RA, Paz P, James EA, Gunasekera D, Aswad F, Thompson AR, Matthews DC, Pratt KP, Blood, 1/1/2016
  • Personalized Approaches to Therapies for Hemophilia (PATH) Study Investigators Factor VIII gene variants and inhibitor risk in African American hemophilia A patients  
    Gunasekera D, Ettinger RA, Nakaya Fletcher S, James EA, Liu M, Barrett JC, Withycombe J, Matthews DC, Epstein MS, Hughes RJ, Pratt KP, Blood, 1/1/2015
  • Eltrombopag for the treatment of children with persistent and chronic immune thrombocytopenia (PETIT): a randomized, multicenter, placebo-controlled study  
    Bussel JB, Garcia de Miguel P, Despotovic JM, Grainger JD, Sevilla J, Blanchette VS, Krishnamurti L, Connor P, David M, Boayue KB, Matthews DC, Lambert MP, Marcello LM..., The Lancet Haematology, 1/1/2015
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Treatment with Eltrombopag in 171 Children with Chronic Immune Thrombocytopenia (ITP).
    Bussel JB, Grainger JD, Garcia de Miguel P, Despotovic JM, Locatelli F, Chotsampancharoen T, Donyush EK et al, American Society of Hematology Annual Meeting, 1/6/2014
  • Factor VIII gene variants and inhibitor risk in African American Hemophilia A patients.
    Gunasekera D, Ettinger RA, Nakaya Fletcher S, James EA, Liu M, Barrett JC, Withycombe J, Matthews DC, Epstein MS, Hughes RJ, Pratte KP, American Society of Hematology Annual Meeting, 1/6/2014
  • Factor VIII proteins having a rationally modified, immunodominant T-cell epitope demonstrate normal procoagulant activity, bind to VWF with high affinity, and are mark...
    Ettinger RA, James EA, Puranik K, Thompson AR, Matthews DC, Pratt KP, American Society of Hematology Annual Meeting, 1/7/2013
  • Join now to see all

Other

  • Hemolytic disease of the fetus and newborn: managing the mother, fetus and newborn. 
    Delaney M, Mathews DC, Hematology Am Soc Hematolol Educ Program
    1/1/2015

Grant Support

  • Radiolabelled Antibody Therapy Of Acute LeukemiaNational Cancer Institute2000–2002
  • Radiolabeled Antibody Mediated ImmunosuppressionNational Cancer Institute1997–2001
  • Cytokine Effects On Localization Of Radiolabeled Anti CD45 AntibodyNational Center For Research Resources1997–1999
  • Antibody Delivered Lymphohematopoietic IrradiationNational Cancer Institute1994
  • Antibody-Delivered Lymphohematopoietic IrradiationNational Cancer Institute1992–1993

Hospital Affiliations